Transforming Drug Development in Heart Failure-Reference-Cited by-同舟云学术

Transforming Drug Development in Heart Failure

Published:2016-10 Issue:10 Volume:9 Page:
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ: Heart Failure

Author:

Vaduganathan Muthiah¹,Butler Javed¹,Gheorghiade Mihai¹

Affiliation:

1. From the Brigham and Women’s Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA (M.V.); Division of Cardiology, Stony Brook University, NY (J.B.); and Center for Cardiovascular Innovation, Northwestern University, Feinberg School of Medicine, Chicago, IL (M.G.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.116.003192

Reference20 articles.

1. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.;Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF);JAMA,2002

2. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

3. Cardiovascular Drug Development

4. Modern Drug Development

5. The disconnect between phase II and phase III trials of drugs for heart failure

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations;Statistics in Biopharmaceutical Research;2020-06-23

2. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials;JAMA Cardiology;2020-06-01

3. HSP90 inhibitor 17‐AAG prevents apoptosis of cardiomyocytes via miR‐93–dependent mitigation of endoplasmic reticulum stress;Journal of Cellular Biochemistry;2018-12-16

4. Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials;JAMA Cardiology;2018-10-01

5. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure;Circulation;2018-09-04